Recently the drug Oridonin has been found to have anti-inflammatory properties, and therefore, this can serve as a lead for developing new therapeutics against NLRP3-associated diseases such as peritonitis, gouty arthritis and type 2 diabetes. The gene discussed is NLRP3; the disease is gout.